4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2019-06-10
Target enrollment:
Participant gender:
Summary
This is a dose-escalating study in patients with Type 2 diabetes on metformin. Participants
will receive an investigational product or placebo for 28 days.